From the Journals

Meta-analysis shows correlation between diabetes and erectile dysfunction


 

FROM DIABETIC MEDICINE

– More than half of men with type 1 or type 2 diabetes develop erectile dysfunction, making them more than three times as likely to develop ED, compared with healthy men, according to a systematic review of diabetes studies.

Data on the exact prevalence of erectile dysfunction in this population has been lacking until now. More precise figures are available from a meta-analysis of 145 studies taken from international diabetes databases.

©Tashatuvango/Thinkstockphotos.com
The prevalence of erectile dysfunction in diabetes overall was 52.5% (95% confidence interval, 48.8-56.2) after adjusting for publication bias, and 37.5%, 66.3%, and 57.7% in type 1, type 2, and both types of diabetes, respectively (P for interaction less than .0001).

In terms of risk, men with diabetes were 3.62 (95% CI, 2.53-5.16; P less than .0001) times more likely to develop ED, compared with healthy controls, according to investigators (Diabet Med. 2017 Jul 18. doi: 10.1111/dme.13403).

“Regarding sexual activity and the psychological impact of erectile dysfunction in men with diabetes mellitus, significant and positive associations have been found between depressive symptoms and erectile dysfunction,” said Youssef Kouidrat, MD, PhD, of the department of psychosis studies, Institute of Psychiatry, King’s College London, and his fellow researchers. “Therefore, early detection of erectile dysfunction is essential to improve the psychological health and men’s quality of life.”

Given ED’s serious effects on patients’ physical and emotional well being, it is essential for physicians to have a better understanding of the root causes of the condition in order to help patients as soon as possible, wrote the investigators.

The studies included in the meta-analysis represented a population of 88.755 men with an average age of 56 years, with dates of the studies ranging from the inception of the databases they were taken from up until November 2016.

A majority of the studies included were conducted in Asia (61), followed by Europe (48), North America (17), Africa (15), and Oceania, South America, and multiple continents (4 in total).

South America reported the highest prevalence of ED (74.6%), while the lowest prevalence reported was among studies in North America (34.5%).

Patients who were assessed using the Sexual Health Inventory for Men (SHIM) score reported a higher ED prevalence (82.2%), as did men above the age of 60 years old (62.2%).

With ED correlated to cardiovascular health and mortality, investigators advise physicians to keep testing in mind when assessing patients’ cardiovascular risk.

This study was limited by incomplete data from studies included, which made it difficult to determine prevalence by certain categories.

Other limitations included the lack of separation between type 1 and type 2 diabetes among many of the studies analyzed, as well as a lack of information from the studies analyzed on other risk factors concerning diabetes-related erectile dysfunction.

Investigators reported no relevant financial disclosures.

On Twitter @eaztweets

Recommended Reading

Red flags for type 2 diabetes seen 25 years before diagnosis
MDedge Endocrinology
Insulin degludec decreases rate, severity of hypoglycemic episodes
MDedge Endocrinology
Adult diabetes up 35% over 25 years
MDedge Endocrinology
Statins linked to fewer deaths, slightly higher HbA1c in T2DM
MDedge Endocrinology
Vancomycin research reveals reasons for readmissions and prolonged stays
MDedge Endocrinology
Intense exercise reduces hypoglycemia awareness in type 1 diabetes
MDedge Endocrinology
Blood markers can detect early pancreatic cancer
MDedge Endocrinology
Even a few middle age pounds are dangerous
MDedge Endocrinology
Over 45% of American adults have type 2 diabetes mellitus or prediabetes
MDedge Endocrinology
Life-long risk reduction could cut late-life dementia by up to 35%
MDedge Endocrinology

Related Articles